YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Natco Pharma

Natco Pharma

BSE: 524816|NSE: NATCOPHARM|ISIN: INE987B01026|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 27, 12:26
1043.80
-12.95 (-1.23%)
VOLUME 12,122
LIVE
NSE
Jul 27, 12:28
1046.75
-10.65 (-1.01%)
VOLUME 274,662
News on Natco Pharma
Select Year: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Natco Pharma; target of Rs 1550: Firstcall Research

12.46 pm | 21 Nov 2014 |  Source: Moneycontrol.com

Brokerage house Firstcall Research is bullish on Natco Pharma and has recommended buy rating on the stock with a target price of Rs 1550 in its resear...

Natco Pharma consolidated Sep '14 sales at Rs 219.23 crore

4.09 pm | 14 Nov 2014 |  Source: Moneycontrol.com

Natco Pharma has reported a consolidated total income from operations of Rs 219.23 crore and a net profit of Rs 32.37 crore for the quarter ended Sep ...

Natco Pharma: Outcome of board meeting

4.55 pm | 12 Nov 2014 |  Source: Moneycontrol.com

Natco Pharma has informed that the Board of Directors of the Company at its meeting held on November 12, 2014, has taken on record the following: 1. M...

Natco Pharma's Q2 results on November 12, 2014

12.29 pm | 31 Oct 2014 |  Source: Moneycontrol.com

Natco Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 12, 2014, inter alia, to consider t...

Natco Pharma receives tentative approval from USFDA

12.18 pm | 21 Oct 2014 |  Source: Moneycontrol.com

Natco Pharma announced that its marketing partner in the USA, Breckenridge Pharmaceuticals, Inc., has received a tentative approval from the USFDA for...

Natco Pharma: Outcome of AGM

9.39 am | 29 Sep 2014 |  Source: Moneycontrol.com

Natco Pharma Ltd has informed BSE that the 31st Annual General Meeting (AGM) of the Company was held on September 27, 2014....

Natco's Kothur formulation facility found acceptable by USFDA

9.50 am | 18 Sep 2014 |  Source: Moneycontrol.com

Natco has received a letter dated July 14th 2014 after completing review of the Establishment Inspection Report (EIR) for the inspection conducted fro...

Buy Natco Pharma: Rahul Arora 

2.21 pm | 12 Sep 2014 |  Source: CNBC-TV18

Rahul Arora, CEO at Nirmal Bang Institutional Equities is of the view that one can buy Natco Pharma at Rs 1500....

Breckenridge/NATCO files ANDA for Everolimus

2.45 pm | 06 Sep 2014 |  Source: Moneycontrol.com

Natco Phramas marketing partner in the USA, Breckenridge Pharmaceutical, Inc has filed an Abbreviated New Drug Application for Everolimus 0.25mg, 0.5...

Natco pharma's US partner files ANDA for Everolimus

6.22 pm | 05 Sep 2014 |  Source: PTI

Novartis AG sells Everolimus 0.25mg, 0.5mg, and 0.75mg Tablets under Brand name Zortress in the USA market....

Natco Pharma: Updates on appointment of additional directors

2.42 pm | 26 Aug 2014 |  Source: Moneycontrol.com

Natco Pharma Ltd has informed BSE that the Exim Bank with drawn their Nominee Director from the Board of Directors and the Board of Directors by way R...

Natco Pharma: Outcome of board meeting

11.18 pm | 12 Aug 2014 |  Source: Moneycontrol.com

Natco Pharma at its meeting held on August 12, 2014, inter alia, taken on record and considered the Board Constituted the Corporate Social Responsibil...

Bombay HC upholds compulsory license to Natco Pharma on Nexavar issue

9.01 am | 16 Jul 2014 |  Source: Moneycontrol.com

Natco is pleased to inform that the Bombay High Court upheld the compulsory license (CL) granted to the Company on Nexavar (sorafenib tosylate) of Ger...

'Licence grant to Natco has a sentimental impact on Cipla' 

5.26 pm | 15 Jul 2014 |  Source: CNBC-TV18

Praful Borah of Nirmal Bang Equities does not see much of a financial impact but it does take off the entire uncertainty of the compulsory licensing....

Natco Pharma may gain 5-8%: Ambareesh Baliga 

4.12 pm | 15 Jul 2014 |  Source: CNBC-TV18

Ambareesh Baliga, Independent Market Analyst is of the view that Lupin and Sun Pharma are the best picks from the pharma space....

See prices of cardiac drugs reduce by 15-50%: Ex-MD Pfizer 

12.12 pm | 14 Jul 2014 |  Source: CNBC-TV18

According to Kewal Handa, the pricing regulator (NPPA) has fixed prices of medicines that are not included in the national list of essential medicines...

Delhi HC doesn't stop Natco from exporting Copaxone generic

9.38 pm | 08 Jul 2014 |  Source: CNBC-TV18

The Delhi HC was hearing a petition filed by Teva, which has alleged patent infringement by Natco. Copaxone is Teva’s blockbuster drug with sales in...

Hold Natco Pharma; target of Rs 1040: ICICIdirect

5.34 pm | 18 Jun 2014 |  Source: Moneycontrol.com

ICICIdirect.com has recommended hold rating on Natco Pharma with a target price of Rs 1040, in its research report dated June 18, 2014....

Buy Natco Pharma; target of Rs 930: Firstcall Research

12.51 pm | 16 Jun 2014 |  Source: Moneycontrol.com

Brokerage house Firstcall Research is bullish on Natco Pharma and has recommended buy rating on the stock with a target price of Rs 930 in its researc...

Delhi HC allows Teva's appeal against Natco 

2.40 pm | 30 May 2014 |  Source: CNBC-TV18

This will provide relief to Israel-based Teva which had moved Delhi HC against Natco alleging patent infringement....

1 2 3
Quick Links for Natco Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.